Salbutamol via Easyhaler® multidose dry powder inhaler produces equivalent relief of histamine-induced bronchoconstriction to salbutamol via pressurised metered-dose inhaler

Clinical Drug Investigation

Volumn 19, Issue 5, 2000, Pages 335-341

  Randell, J ^a   Hämäläinen, Kaisa Mari ^b   Leinonen, M ^b   Keski Karhu, J ^b   Silvasti, M ^b   Tukiainen, H ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b ORION CORPORATION   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; SALBUTAMOL;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BRONCHODILATING ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRY POWDER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; METERED DOSE INHALER; PATIENT SATISFACTION; PRIORITY JOURNAL; PROVOCATION TEST; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; VITAL CAPACITY;

EID: 0034032532     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200019050-00003     Document Type: Article

References (16)

1. 1. European Commission. Communication from the Commission to the Council and the European Parliament: strategy for the phaseout of CFCs in metered-dose inhalers. (98/C 355/02) Official Journal of the European Communities C355/1-C355/30:20.11.98
2. 2. Partridge MR, Woodcock AA, Sheffer AL, et al. Chlorofluorocarbon-free inhalers: are we ready for the change? Eur Respir J 1998; 11: 1006-8
3. 3. Woodcock A, Custovic A, Smith A. Metered dose inhalers: the need for change. Eur Respir Rev 1998; 8 (53): 179-80
4. 4. Vidgren M, Silvasti M, Vidgren P, et al. Easyhaler® multiple dose powder inhaler - practical and effective alternative to the pressurized MDI. Aerosol Sci Technol 1995; 22 (4): 335-45
5. 2-adrenoceptors. Eur Respir Rev 1998; 8 (55): 210-5
6. 6. Cockcroft DW, Killian DN, Mellon JJA, et al. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 235-43
7. 7. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report of the Working Party. Standardization of Lung Function Testing. European Community for Steel and Coal. Official Statment of the European Respiratory Society. Eur Respir J 1993; 145: 1321-7
8. 8. National Heart, Lung, and Blood Institute. International consensus report on diagnosis and treatment of asthma. Eur Respir J 1992; 5; 601-41
9. 9. Foster RW. Assessment of bronchodilator potency/effectiveness in the normal subject. In: Small R, Johnson M, editors. β-Adrenoceptor agonists and the airways. The Royal Society of Medicine; London, 1995: 63-78
10. 10. Polosa R, Prosperini G, Magri S, et al. Bronchodilator response to salbutamol after spontaneous recovery from nonspecific bronchial provocation tests in asthma. Eur Respir J 1998; 11: 1086-90
11. 11. Nieminen MM, Vidgren M, Laurikainen K, et al. Easyhaler®, a novel multiple dose powder inhaler: clinically equivalent to salbutamol metered dose inhaler and easier to use. Respiration 1994; 61: 37-41
12. 12. Tammivaara R, Aalto E, Lehtonen K, et al. Comparison of a novel salbutamol multidose powder inhaler with a salbutamol metered dose inhaler in patients with asthma. Curr Ther Res I997 Oct; 58 (10): 734-44
13. 13. Ahonen A, Leinonen M, Ranki-Pesonen M. Acceptability of inhalation devices in the treatment of asthma. A meta-analysis [abstract]. XXXIX Nordic Respiratory Congress, Copenhagen, 10-12 June 1999. Norweg Resp J 1999; 9: Suppl 11: 9
14. 14. Haahtela T, Ahonen A, Hämäläinen KM, et al. Histamine-induced broncho-constriction is equally relieved by Easyhaler® and Diskhaler® salbutamol powder inhalers. Clin Drug Invest 1998 Nov; 16(5): 371-6
15. 15. Laurikainen K, Silvasti M, Calderon P, et al. Comparison of bronchodilating effects of two salbutamol dry powder inhalers in asthmatic patients. Arzneimittelforschung 1997; 47 (1): 44-6
16. 16. Chapman KR. Effect of the inhaled route of administration on compliance in asthma. Eur Respir Rev 1998; 8 (56): 275-9